NCT00001672
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +4 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Clinical trial condition
Epilepsy
Explore clinical trials studying Epilepsy. Study availability and eligibility vary by location and protocol.
323 public trials
75 recruiting studies
Epilepsy trial results
NCT00006191
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dyskinesias, +11 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00001666
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +7 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00001325
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +18 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Completed
To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141245
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
- Locations
-
- Pfizer Investigational Site Deakin, Australian Capital Territory, Australia
- Pfizer Investigational Site Chatswood, New South Wales, Australia
- Pfizer Investigational Site Westmead, New South Wales, Australia
- Pfizer Investigational Site Maroochydore, Queensland, Australia
NCT00141414
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
- Locations
-
- Pfizer Investigational Site Little Rock, Arkansas, United States
- Pfizer Investigational Site Los Angeles, California, United States
- Pfizer Investigational Site Stanford, California, United States
- Pfizer Investigational Site Miami, Florida, United States
Completed
To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.
NCT00141336
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Bakersfield, California, United States
- Pfizer Investigational Site Berkeley, California, United States
NCT00143143
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Partial, +3 more
- Locations
-
- Pfizer Investigational Site Innsbruck, Austria
- Pfizer Investigational Site Mauer bei Amstetten, Austria
- Pfizer Investigational Site Sankt Pölten, Austria
- Pfizer Investigational Site Vienna, Austria
Completed
Phase III Double Blind Trial of Valproate Sodium for Prophylaxis of Post Traumatic Seizures
NCT00004817
- Conditions
- Brain Diseases, Brain Injuries, Central Nervous System Diseases, +16 more
- Locations
-
Not specified
Active, Not Recruiting
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
NCT05823766
- Conditions
- Brain Diseases, Brain Injuries, Brain Injuries, Traumatic, +9 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
- Spaulding Rehabilitation Hospital Charlestown, Massachusetts, United States
- University of Cincinnati Cincinnati, Ohio, United States
- University of Pennsylvania/Penn Presbyterian Medical Center Philadelphia, Pennsylvania, United States